Drugs that contain Itraconazole
1. Onmel patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6509038 | SEBELA IRELAND LTD | Antifungal compositions with improved bioavailability |
May, 2017
(6 years ago) | |
| US7081255 | SEBELA IRELAND LTD | Antifungal compositions with improved bioavailability |
May, 2017
(6 years ago) | |
| US8591948 | SEBELA IRELAND LTD | Antifungal compositions with improved bioavailability |
May, 2017
(6 years ago) | |
| US8486456 | SEBELA IRELAND LTD | Itraconazole compositions with improved bioavailability |
Oct, 2028
(4 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Apr 29, 2013 |
Market Authorisation Date: 29 April, 2010
Treatment: Onychomycosis of the toenail caused by tricophyton rubrum or trichophyton mentagrophytes, once daily use for 12 consecutive weeks
Dosage: TABLET;ORAL
More Information on Dosage
ONMEL family patents
2. Sporanox patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5633015 | JANSSEN PHARMS | Beads having a core coated with an antifungal and a polymer |
May, 2014
(9 years ago) | |
| US5707975 | JANSSEN PHARMS | Oral formulations on an antifungal |
Jan, 2015
(9 years ago) | |
| US6407079 | JANSSEN PHARMS | Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation |
Jun, 2019
(4 years ago) | |
Market Authorisation Date: 11 September, 1992
Treatment: NA
Dosage: CAPSULE;ORAL; INJECTABLE;INJECTION
How can I launch a generic of SPORANOX before it's drug patent expiration?
More Information on Dosage
SPORANOX family patents
3. Tolsura patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8771739 | MAYNE PHARMA | Pharmaceutical compositions for poorly soluble drugs |
Jul, 2023
(9 months ago) | |
| US9272046 | MAYNE PHARMA | Itraconazole compositions and dosage forms, and methods of using the same |
Jun, 2033
(9 years from now) | |
| US10806792 | MAYNE PHARMA | Itraconazole compositions and dosage forms, and methods of using the same |
Jun, 2033
(9 years from now) | |
| US10463740 | MAYNE PHARMA | Itraconazole compositions and dosage forms, and methods of using the same |
Jun, 2033
(9 years from now) | |
| US8921374 | MAYNE PHARMA | Itraconazole compositions and dosage forms, and methods of using the same |
Jun, 2033
(9 years from now) | |
| US9713642 | MAYNE PHARMA | Itraconazole compositions and dosage forms, and methods of using the same |
Jun, 2033
(9 years from now) | |
Market Authorisation Date: 11 December, 2018
Treatment: Treatment of fungal infections, including blastomycosis, histoplasmosis, and aspergillosis
Dosage: CAPSULE;ORAL
More Information on Dosage
TOLSURA family patents